From Figures to Values: The Implicit Ethical Judgements in our Measures of Health
Public Health Ethics 5 (1):22-28 (forthcoming)
| Abstract | The objective of the article is to examine the extensions of a clinical measure of efficacy, the Number Needed to Treat (NNT), in different settings including screening, scanning, genetic testing and primary prevention, and the associated ethical implications. We examine several situations in which the use of the NNT or NNS (Number Needed to Screen) has been suggested, such as Prostate-Specific Antigen for prostate cancer, Magnetic Resonance Imaging scans, genetic testing and banning of smoking. For each application, we explore the ethical implications of the relevant measure. We have found that the different measures have different ethical implications. For example, the Number Needed to Prevent is the only measure that can be lower than one, indicating with a numerical example that prevention is better than cure. Conversely, we raise questions about the acceptability of genetic screening. In a realistic example, we show that primary prevention of the effects of arsenic in drinking water, targeted to the most susceptible, would require to genetically screen a large number of subjects, whereas giving rise to ethical concerns. We warn against the abuse of testing, in particular genetic testing, we show that different measures are associated with different ethical issues and that prevention tends to be better than cure | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,672 |
| External links |
|
| Through your library | Configure |
Michael D. Mumford, Lynn D. Devenport, Ryan P. Brown, Shane Connelly, Stephen T. Murphy, Jason H. Hill & Alison L. Antes (2006). Articles: Validation of Ethical Decision Making Measures: Evidence for a New Set of Measures. Ethics and Behavior 16 (4):319 – 345.
Claudia Wild (2007). Polymorphism-Screening: Genetic Testing for Predisposition—Guidance for Technology Assessment. Poiesis and Praxis 5 (1):1-14.
Cheryl Berg & Kelly Fryer-Edwards (2008). The Ethical Challenges of Direct-to-Consumer Genetic Testing. Journal of Business Ethics 77 (1):17 - 31.
Lainie Friedman Ross (2002). Predictive Genetic Testing for Conditions That Present in Childhood. Kennedy Institute of Ethics Journal 12 (3):225-244.
Aisling Sheehan & Hannah McGee (2013). Screening for Depression in Medical Research: Ethical Challenges and Recommendations. BMC Medical Ethics 14 (1):1-4.
Aisling Sheehan & Hannah McGee (2013). Screening for Depression in Medical Research: Ethical Challenges and Recommendations. BMC Medical Ethics 14 (1):1-4.
Stuart Rennie & Bavon Mupenda (2008). Ethics of Mandatory Premarital Hiv Testing in Africa: The Case of Goma, Democratic Republic of Congo. Developing World Bioethics 8 (2):126-137.
Aisling M. Sheehan & Hannah McGee (2013). Screening for Depression in Medical Research: Ethical Challenges and Recommendations. BMC Medical Ethics 14 (1):4-.
Lynn D. Devenport, Ryan P. Brown, Stephen T. Murphy, Alison L. Antes, Ethan P. Waples, Michael D. Mumford & Shane Connelly (2009). Exposure to Unethical Career Events: Effects on Decision Making, Climate, and Socialization. Ethics and Behavior 19 (5):351-378.
Michael Waxman, Roland Merchant, M. Celada & Melissa Clark (2011). Perspectives on the Ethical Concerns and Justifications of the 2006 Centers for Disease Control and Prevention HIV Testing Recommendations. BMC Medical Ethics (1):24-.
Dagmar Schmitz (forthcoming). A New Era in Prenatal Testing: Are We Prepared? Medicine, Health Care and Philosophy.
Edison J. Trickett (1992). Prevention Ethics: Explicating the Context of Prevention Activities. Ethics and Behavior 2 (2):91 – 100.
Monthly downloads
Sorry, there are not enough data points to plot this chart.
|
Added to index2012-03-23Total downloads0Recent downloads (6 months)0How can I increase my downloads? |

